Former Professional Fighters League heavyweight champion Bruno Cappelozza has been suspended one year for failing an out-of-competition drug test.
Cappelozza tested positive for clomiphene and its metabolite, desethyl-clomifene, in a urine sample collected on April 17, 2024. Clomiphene is in the category of hormone and metabolic modulators and is banned at all times under the PFL anti-doping policy. Cappelozza will be eligible to return to active competition on April 17, 2025.
It’s the second failed drug test for Cappelozza, who tested positive for drostanolone in relation to a PFL regular season bout against Matheus Scheffel on April 7, 2023. That resulted in a nine-month suspension for the Brazilian, whose knockout of Scheffel was also overturned to a no contest.
Cappelozza returned to action for the first time since that sanction at the PFL vs. Bellator Champs event on Feb. 24, when he suffered a second-round submission loss to former Bellator light heavyweight champion Vadim Nemkov. Cappelozza notably captured the PFL heavyweight title in 2021, winning four consecutive bouts over the course of that campaign.
Cappelozza is the second PFL athlete to be suspended since the promotion began its partnership with USADA. In July, Gokhan Saricam was suspended for one year after testing positive for clomiphene in a pair of out-of-competition screenings.
